Watchlists Portfolios Alerts Sign in Get started

Menu

Shattuck Labs, Inc. STTK

Full chart Compare

Set alert

4.62 USD +0.13 (+2.90%)

At closeNov 6, 2026, 4:27 PM EST

4.62 0.00 0.00%

After hours · Nov 6, 4:27 PM ET

4.38 Day range 4.76

1.84 52-week range 8.06

YTD: +26.58%
1 year: +135.71%

News

2 days ago globenewswire.com Shattuck Labs Reports Third Quarter 2026 Financial Results and Recent Business Highlights – Initiated the RECEPTIVE-CD1 Phase 2b clinical trial of SL-325 in Crohn's disease; 12-week induction data expected in the first half of 2028 – – Announced RECEPTIVE-HS1 Phase 2 clinical trial of…
3 weeks ago benzinga.com UBS Initiates Coverage On Shattuck Labs with Buy Rating, Announces Price Target of $17 UBS analyst Alice Nettleton initiates coverage on Shattuck Labs (NASDAQ:STTK) with a Buy rating and announces Price Target of $17.